Conference
COSTS COMPARISON BETWEEN DUPILUMAB AND OMALIZUMAB IN THE TREATMENT OF SEVERE ALLERGIC ASTHMA IN THE BRAZILIAN PRIVATE HEALTHCARE PERSPECTIVE
Authors
Barbosa A; Magro FJB; Taminato A; Federico P; Prioli RNT; Goldflus S; Migliavaca CB; Falavigna M
Volume
25
Pagination
pp. S164-S164
Publisher
ELSEVIER SCIENCE INC
Publication Date
December 1, 2022
Conference proceedings
VALUE IN HEALTH
Issue
12
ISSN
1098-3015